Hoth Therapeutics Inc (HOTH)

$1.31 +0.00 (0.38%)
Market Cap 17.17M
Revenue (ttm) 0.00
Net Income (ttm) -8.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 457,806
Avg Vol 1,219,558
Day's Range N/A - N/A
Shares Out 13.21M
Stochastic %K 47%
Beta 0.55
Analysts Strong Sell
Price Target $4.00

Company Profile

Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It develops HT-001, a topical formulation in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke; HT-ALZ for th...

Industry: Biotechnology
Sector: Healthcare
Phone: (646) 756-2997
Address:
1177 Avenue of the Americas, Suite 5066 5th Floor, New York, United States
DexterTrader
DexterTrader Jun. 16 at 8:05 PM
Looks like people are starting to shift in to ticker ULY now. Huge insider buying going on! Float is so tiny here only 780k shares. once 5$ breaks this could move into 10-15$ range real fast from there… Something is brewing on ticker ULY - could be this weeks top micro float runner! $KIDZ $KAPA $HOTH $WORX ms
0 · Reply
WallStreetReporter
WallStreetReporter Jun. 16 at 6:43 PM
$HOTH #livestream tomorrow!! 🚀🚀🚀 https://youtube.com/live/KhFa2QsjHkI?feature=share
0 · Reply
canadianpennystockhunter
canadianpennystockhunter Jun. 16 at 6:23 PM
$HOTH
0 · Reply
WallStreetReporter
WallStreetReporter Jun. 16 at 6:23 PM
$HOTH #BREAKOUT on 1hr #stockCharts $2.50 NEXT??
0 · Reply
WallStreetReporter
WallStreetReporter Jun. 16 at 6:22 PM
$HOTH 🚀🚀🚀🚀 #BREAKINGOUT #BREAKOUTSTOCKS LOOK at this #stockCharts #BREAKOUT above MA $1.50 then $2.50 next target ESCAPE VELOCITY!! @BreakoutStocks @PeloSwing @MrZackMorris
0 · Reply
Thunderandlightning
Thunderandlightning Jun. 16 at 6:16 PM
$HOTH
0 · Reply
canadianpennystockhunter
canadianpennystockhunter Jun. 16 at 4:28 PM
$HOTH
0 · Reply
canadianpennystockhunter
canadianpennystockhunter Jun. 16 at 3:01 PM
$HOTH
0 · Reply
companyofone
companyofone Jun. 16 at 2:21 PM
$HOTH can this stay above a $1 until Thursday is the question.
1 · Reply
Eaa125
Eaa125 Jun. 16 at 1:36 PM
$HOTH 4 hour chart still looking JUICY!
0 · Reply
Latest News on HOTH
Hoth Therapeutics to Attend 2025 BIO International Convention

Jun 16, 2025, 8:00 AM EDT - 8 hours ago

Hoth Therapeutics to Attend 2025 BIO International Convention

Hoth Therapeutics Secures Japanese Patent for Breakthrough HT-KIT Platform Targeting Mast Cell Diseases

Jun 12, 2025, 9:17 AM EDT - 4 days ago

Hoth Therapeutics Secures Japanese Patent for Breakthrough HT-KIT Platform Targeting Mast Cell Diseases

Hoth Therapeutics Launches Expanded Access Initiative for HT-001, Offering Critical Relief to Cancer Patients Facing Severe Skin Toxicities

Jun 11, 2025, 8:28 AM EDT - 5 days ago

Hoth Therapeutics Launches Expanded Access Initiative for HT-001, Offering Critical Relief to Cancer Patients Facing Severe Skin Toxicities

Hoth Therapeutics to Spotlight HT-001 in Investor-Focused KOL Event Addressing Breakthrough Combating Cancer Treatment Skin Toxicities

Jun 5, 2025, 8:12 AM EDT - 11 days ago

Hoth Therapeutics to Spotlight HT-001 in Investor-Focused KOL Event Addressing Breakthrough Combating Cancer Treatment Skin Toxicities

Hoth Therapeutics Reports Positive Preclinical Results for HT-KIT, a Precision Antisense Therapy Targeting Rare and Aggressive KIT-Driven Cancers

May 12, 2025, 7:30 AM EDT - 5 weeks ago

Hoth Therapeutics Reports Positive Preclinical Results for HT-KIT, a Precision Antisense Therapy Targeting Rare and Aggressive KIT-Driven Cancers

Hoth Therapeutics Announces Granted Japanese Patent for Novel RNA-Based Cancer Therapy Targeting KIT Gene - Expands Global IP in Precision Oncology Platform

Apr 17, 2025, 8:01 AM EDT - 2 months ago

Hoth Therapeutics Announces Granted Japanese Patent for Novel RNA-Based Cancer Therapy Targeting KIT Gene - Expands Global IP in Precision Oncology Platform

Hoth Therapeutics Announces Positive Initial Data in Phase 2a Clinical Trial

Apr 15, 2025, 8:19 AM EDT - 2 months ago

Hoth Therapeutics Announces Positive Initial Data in Phase 2a Clinical Trial

Hoth Therapeutics Collaborates with Washington University on NIH Grant Application Advancing Alzheimer's Program Using NK-1 Receptor Antagonist HT-ALZ

Apr 2, 2025, 8:02 AM EDT - 2 months ago

Hoth Therapeutics Collaborates with Washington University on NIH Grant Application Advancing Alzheimer's Program Using NK-1 Receptor Antagonist HT-ALZ

Hoth Therapeutics Announces Positive Pre Clinical Data HT-ALZ Shows Promising Breakthrough in Alzheimer's Disease Research Acute treatment with HT-ALZ led to a rapid (~15%) reduction in brain interstitial fluid Aβ levels, within 20 hours

Apr 2, 2025, 7:58 AM EDT - 2 months ago

Hoth Therapeutics Announces Positive Pre Clinical Data HT-ALZ Shows Promising Breakthrough in Alzheimer's Disease Research Acute treatment with HT-ALZ led to a rapid (~15%) reduction in brain interstitial fluid Aβ levels, within 20 hours

Hoth Therapeutics Receives USPTO Filing Receipt for HT-001 Formulation Patent Application, Expanding Existing Patent Coverage

Mar 31, 2025, 4:45 PM EDT - 2 months ago

Hoth Therapeutics Receives USPTO Filing Receipt for HT-001 Formulation Patent Application, Expanding Existing Patent Coverage

Hoth Therapeutics Advances Cancer Fighting HT-KIT Program with New Patent Filing and Preclinical Study Initiation

Mar 26, 2025, 8:02 AM EDT - 2 months ago

Hoth Therapeutics Advances Cancer Fighting HT-KIT Program with New Patent Filing and Preclinical Study Initiation

Hoth Therapeutics Announces Positive Preclinical Results for HT-KIT in Aggressive Cancer Gastrointestinal Stromal Tumors (GIST). HT-KIT Triggered Significant Tumor Cell Death as Early as 24 Hours Post-treatment

Mar 18, 2025, 8:06 AM EDT - 3 months ago

Hoth Therapeutics Announces Positive Preclinical Results for HT-KIT in Aggressive Cancer Gastrointestinal Stromal Tumors (GIST). HT-KIT Triggered Significant Tumor Cell Death as Early as 24 Hours Post-treatment

Hoth Therapeutics Announces Plans to Submit Expanded Access Application for HT-001 to Support Cancer Patients in Need

Mar 10, 2025, 8:02 AM EDT - 3 months ago

Hoth Therapeutics Announces Plans to Submit Expanded Access Application for HT-001 to Support Cancer Patients in Need

Hoth Therapeutics Announces Positive Results for HT-001 in Treating EGFR Inhibitor-Associated Papulopustular Eruptions Findings to be Presented at the American Academy of Dermatology 2025 Annual Meeting

Mar 5, 2025, 1:40 PM EST - 3 months ago

Hoth Therapeutics Announces Positive Results for HT-001 in Treating EGFR Inhibitor-Associated Papulopustular Eruptions Findings to be Presented at the American Academy of Dermatology 2025 Annual Meeting

Hoth Therapeutics Announces Positive Findings on GDNF's Potential as a Game-Changer in Obesity Treatment and Reduced Fatty Liver Disease

Mar 4, 2025, 8:16 AM EST - 3 months ago

Hoth Therapeutics Announces Positive Findings on GDNF's Potential as a Game-Changer in Obesity Treatment and Reduced Fatty Liver Disease

Hoth Therapeutics Partners with OnTargetx R&D to Advance Research for Cancer fighting HT-KIT Cancer Therapeutic

Feb 10, 2025, 8:22 AM EST - 4 months ago

Hoth Therapeutics Partners with OnTargetx R&D to Advance Research for Cancer fighting HT-KIT Cancer Therapeutic

Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements

Jan 24, 2025, 8:29 AM EST - 5 months ago

Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements

Hoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent Applications

Jan 21, 2025, 8:29 AM EST - 5 months ago

Hoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent Applications

Hoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025

Jan 17, 2025, 8:29 AM EST - 5 months ago

Hoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025

Hoth Therapeutics Responds to Market Rumors and Shareholder Inquiries

Jan 8, 2025, 1:27 PM EST - 5 months ago

Hoth Therapeutics Responds to Market Rumors and Shareholder Inquiries

Why Is Hoth Therapeutics Stock Flying Higher On Tuesday?

Jan 7, 2025, 11:53 AM EST - 5 months ago

Why Is Hoth Therapeutics Stock Flying Higher On Tuesday?

Hoth Therapeutics Achieves Breakthrough in Phase 2a Trial: HT-001 Delivers 100% Success in Combating Cancer Treatment Skin Toxicities

Jan 7, 2025, 8:29 AM EST - 5 months ago

Hoth Therapeutics Achieves Breakthrough in Phase 2a Trial: HT-001 Delivers 100% Success in Combating Cancer Treatment Skin Toxicities

Hoth Therapeutics Enters Partnership with the Department of Veterans Affairs to Develop Obesity Treatment

Dec 26, 2024, 7:58 AM EST - 6 months ago

Hoth Therapeutics Enters Partnership with the Department of Veterans Affairs to Develop Obesity Treatment

Hoth Therapeutics Board of Directors Approves Bitcoin as Treasury Reserve Asset

Nov 20, 2024, 7:38 AM EST - 7 months ago

Hoth Therapeutics Board of Directors Approves Bitcoin as Treasury Reserve Asset

Hoth Therapeutics Announces Update on Cancer Therapeutic HT-KIT Results Suggesting the Treatment Effectively Inhibited Tumor Growth in Preclinical Treatment Study

Oct 29, 2024, 12:43 PM EDT - 8 months ago

Hoth Therapeutics Announces Update on Cancer Therapeutic HT-KIT Results Suggesting the Treatment Effectively Inhibited Tumor Growth in Preclinical Treatment Study

Hoth Therapeutics Awarded Key US Patent for Groundbreaking Alzheimer's Treatment and Prepares for Clinical Trials of HT-ALZ with Formulation Now Underway

Oct 15, 2024, 6:38 AM EDT - 8 months ago

Hoth Therapeutics Awarded Key US Patent for Groundbreaking Alzheimer's Treatment and Prepares for Clinical Trials of HT-ALZ with Formulation Now Underway

Hoth Therapeutics Announces Promising Preclinical Results for Alzheimer's Drug HT-ALZ

Sep 17, 2024, 7:57 AM EDT - 9 months ago

Hoth Therapeutics Announces Promising Preclinical Results for Alzheimer's Drug HT-ALZ

Hoth Therapeutics Announces Expansion of Clinical Sites for HT-001 Phase 2a Trial

Sep 5, 2024, 10:32 AM EDT - 10 months ago

Hoth Therapeutics Announces Expansion of Clinical Sites for HT-001 Phase 2a Trial

Hoth Therapeutics Announces Positive Data from First-of-its-Kind Human Patient Treatment of EGFRI-Associated Skin Toxicities with HT-001

Sep 5, 2024, 8:03 AM EDT - 10 months ago

Hoth Therapeutics Announces Positive Data from First-of-its-Kind Human Patient Treatment of EGFRI-Associated Skin Toxicities with HT-001

Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer Therapeutic

Aug 15, 2024, 8:04 AM EDT - 10 months ago

Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer Therapeutic

Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment

Jul 24, 2024, 6:30 AM EDT - 11 months ago

Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment

Hoth Therapeutics Expands Clinical Trial for Cancer Patients

Jul 16, 2024, 8:31 AM EDT - 11 months ago

Hoth Therapeutics Expands Clinical Trial for Cancer Patients

Hoth Therapeutics Announces Joint Development Agreement with Wise Systems International SRL to Utilize Artificial Intelligence for Drug Discovery

Jun 10, 2024, 8:11 AM EDT - 1 year ago

Hoth Therapeutics Announces Joint Development Agreement with Wise Systems International SRL to Utilize Artificial Intelligence for Drug Discovery

Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024

May 1, 2024, 8:00 AM EDT - 1 year ago

Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024

Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds

Mar 27, 2024, 2:00 PM EDT - 1 year ago

Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds

Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment

Mar 27, 2024, 8:27 AM EDT - 1 year ago

Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment

Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ

Mar 19, 2024, 8:21 AM EDT - 1 year ago

Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ

Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio

Feb 29, 2024, 8:38 AM EST - 1 year ago

Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio

Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting Therapeutic

Feb 26, 2024, 8:11 AM EST - 1 year ago

Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting Therapeutic

Hoth Therapeutics to Attend BIO CEO and Investor Conference, February 26-27, 2024

Feb 13, 2024, 11:45 AM EST - 1 year ago

Hoth Therapeutics to Attend BIO CEO and Investor Conference, February 26-27, 2024

Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients

Jan 18, 2024, 8:20 AM EST - 1 year ago

Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients

Hoth Therapeutics Announces it Has Successfully Completed Manufacturing of its Cancer fighting HT-KIT for IND-Enabling Studies

Dec 5, 2023, 8:33 AM EST - 1 year ago

Hoth Therapeutics Announces it Has Successfully Completed Manufacturing of its Cancer fighting HT-KIT for IND-Enabling Studies

Hoth Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA Regarding Development of Hoth's Cancer Fighting HT-KIT

Nov 14, 2023, 8:37 AM EST - 1 year ago

Hoth Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA Regarding Development of Hoth's Cancer Fighting HT-KIT

Hoth Therapeutics to Present at NobleCon's 19th Annual Emerging Growth Investor Conference, December 3-5, 2023

Nov 10, 2023, 8:00 AM EST - 1 year ago

Hoth Therapeutics to Present at NobleCon's 19th Annual Emerging Growth Investor Conference, December 3-5, 2023

Hoth Therapeutics Announces Merveille.ai Artificial intelligence Initiative for Drug Discovery

Oct 5, 2023, 10:03 AM EDT - 1 year ago

Hoth Therapeutics Announces Merveille.ai Artificial intelligence Initiative for Drug Discovery

FDA Grants Hoth Therapeutics Pre-IND Meeting for HT-KIT, Treatment for Cancer Patients

Oct 2, 2023, 8:33 AM EDT - 1 year ago

FDA Grants Hoth Therapeutics Pre-IND Meeting for HT-KIT, Treatment for Cancer Patients

Hoth Therapeutics Announces Closing of $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Sep 15, 2023, 2:38 PM EDT - 1 year ago

Hoth Therapeutics Announces Closing of $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Hoth Therapeutics Announces $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Sep 13, 2023, 1:43 PM EDT - 1 year ago

Hoth Therapeutics Announces $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Hoth Therapeutics Announces Positive Results Killing Cancer Cells in Both Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia

Sep 13, 2023, 8:16 AM EDT - 1 year ago

Hoth Therapeutics Announces Positive Results Killing Cancer Cells in Both Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia

Hoth Therapeutics Announces FDA Accepts Pre-Investigational New Drug (Pre-IND) Submission for HT-KIT, Treatment for Cancer Patients

Sep 11, 2023, 10:04 AM EDT - 1 year ago

Hoth Therapeutics Announces FDA Accepts Pre-Investigational New Drug (Pre-IND) Submission for HT-KIT, Treatment for Cancer Patients

DexterTrader
DexterTrader Jun. 16 at 8:05 PM
Looks like people are starting to shift in to ticker ULY now. Huge insider buying going on! Float is so tiny here only 780k shares. once 5$ breaks this could move into 10-15$ range real fast from there… Something is brewing on ticker ULY - could be this weeks top micro float runner! $KIDZ $KAPA $HOTH $WORX ms
0 · Reply
WallStreetReporter
WallStreetReporter Jun. 16 at 6:43 PM
$HOTH #livestream tomorrow!! 🚀🚀🚀 https://youtube.com/live/KhFa2QsjHkI?feature=share
0 · Reply
canadianpennystockhunter
canadianpennystockhunter Jun. 16 at 6:23 PM
$HOTH
0 · Reply
WallStreetReporter
WallStreetReporter Jun. 16 at 6:23 PM
$HOTH #BREAKOUT on 1hr #stockCharts $2.50 NEXT??
0 · Reply
WallStreetReporter
WallStreetReporter Jun. 16 at 6:22 PM
$HOTH 🚀🚀🚀🚀 #BREAKINGOUT #BREAKOUTSTOCKS LOOK at this #stockCharts #BREAKOUT above MA $1.50 then $2.50 next target ESCAPE VELOCITY!! @BreakoutStocks @PeloSwing @MrZackMorris
0 · Reply
Thunderandlightning
Thunderandlightning Jun. 16 at 6:16 PM
$HOTH
0 · Reply
canadianpennystockhunter
canadianpennystockhunter Jun. 16 at 4:28 PM
$HOTH
0 · Reply
canadianpennystockhunter
canadianpennystockhunter Jun. 16 at 3:01 PM
$HOTH
0 · Reply
companyofone
companyofone Jun. 16 at 2:21 PM
$HOTH can this stay above a $1 until Thursday is the question.
1 · Reply
Eaa125
Eaa125 Jun. 16 at 1:36 PM
$HOTH 4 hour chart still looking JUICY!
0 · Reply
canadianpennystockhunter
canadianpennystockhunter Jun. 16 at 1:30 PM
$HOTH
0 · Reply
WallStreetReporter
WallStreetReporter Jun. 16 at 1:17 PM
$HOTH #CEO #livestream TOMORROW 1PM 🚀🚀🚀 NEWS??🌋🌋🌋 https://youtube.com/live/KhFa2QsjHkI
1 · Reply
YasirTrades
YasirTrades Jun. 16 at 11:32 AM
TICKER = THE BEST SMALL CAP SWING LIFE CHANGING RUN FOR GLMD COMING is ticking, catalyst around the corner Trading under cash with a $20+ cash + book , no debt, and a tiny float. GLP-1 + Chart coiled. When volume hits, this could explode 100%+ fast.(prob more) $RBNE $LTRY $HOTH $GME ….
0 · Reply
canadianpennystockhunter
canadianpennystockhunter Jun. 14 at 11:51 PM
$HOTH @WallStreetReporter
0 · Reply
MasterofThePennies
MasterofThePennies Jun. 14 at 6:40 PM
$HOTH good video to watch if you are in this stock https://www.tiktok.com/t/ZTjteJF2x/ $MLGO $ICON watching as well.
0 · Reply
AstroSwings
AstroSwings Jun. 14 at 3:17 PM
$HOTH Three recent news releases, looks like a solid swing in my opinion
0 · Reply
canadianpennystockhunter
canadianpennystockhunter Jun. 13 at 4:14 PM
$HOTH
0 · Reply
SakMG00d
SakMG00d Jun. 13 at 4:10 PM
$HOTH
0 · Reply
Eaa125
Eaa125 Jun. 13 at 4:02 PM
$HOTH here we go. Told ya!
0 · Reply
WallStreetReporter
WallStreetReporter Jun. 13 at 3:41 PM
$HOTH 🌋🌋🌋 bouncing off support line at 50MA 🚀 Watch for gap close at $1.45 then test of $1.55 resistance. ESCAPE VELOCITY above $2.00🚀🚀🚀 💰💰💰
0 · Reply
canadianpennystockhunter
canadianpennystockhunter Jun. 13 at 3:33 PM
$HOTH
0 · Reply
Eaa125
Eaa125 Jun. 13 at 2:34 PM
$HOTH got the cool off, now we can run up! Might take some time but slow and steady wins the race. Buy and hodl
0 · Reply